CN106916799B - A Ppmar1 transposase D332S mutant with high catalytic activity and its application - Google Patents
A Ppmar1 transposase D332S mutant with high catalytic activity and its application Download PDFInfo
- Publication number
- CN106916799B CN106916799B CN201710042523.6A CN201710042523A CN106916799B CN 106916799 B CN106916799 B CN 106916799B CN 201710042523 A CN201710042523 A CN 201710042523A CN 106916799 B CN106916799 B CN 106916799B
- Authority
- CN
- China
- Prior art keywords
- leu
- transposase
- ppmar1
- lys
- mutant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000008579 Transposases Human genes 0.000 title claims abstract description 74
- 108010020764 Transposases Proteins 0.000 title claims abstract description 74
- 230000003197 catalytic effect Effects 0.000 title claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- 239000002773 nucleotide Substances 0.000 claims abstract description 14
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 14
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 239000013612 plasmid Substances 0.000 claims description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 12
- 238000010276 construction Methods 0.000 claims description 4
- 230000017105 transposition Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 7
- 238000011161 development Methods 0.000 abstract description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract description 2
- 235000003704 aspartic acid Nutrition 0.000 abstract description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract description 2
- 238000002955 isolation Methods 0.000 abstract description 2
- 239000013598 vector Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 10
- 238000012408 PCR amplification Methods 0.000 description 9
- 239000012634 fragment Substances 0.000 description 8
- 239000008223 sterile water Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000029087 digestion Effects 0.000 description 7
- 244000302661 Phyllostachys pubescens Species 0.000 description 6
- 235000003570 Phyllostachys pubescens Nutrition 0.000 description 6
- 101150096273 ADE2 gene Proteins 0.000 description 5
- 102000012410 DNA Ligases Human genes 0.000 description 5
- 108010061982 DNA Ligases Proteins 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- CLUMZOKVGUWUFD-CIUDSAMLSA-N Asp-Leu-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O CLUMZOKVGUWUFD-CIUDSAMLSA-N 0.000 description 4
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 4
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 108010013835 arginine glutamate Proteins 0.000 description 4
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 4
- 108010047857 aspartylglycine Proteins 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 238000012257 pre-denaturation Methods 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 2
- CSAHOYQKNHGDHX-ACZMJKKPSA-N Ala-Gln-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CSAHOYQKNHGDHX-ACZMJKKPSA-N 0.000 description 2
- NYDBKUNVSALYPX-NAKRPEOUSA-N Ala-Ile-Arg Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NYDBKUNVSALYPX-NAKRPEOUSA-N 0.000 description 2
- GKAZXNDATBWNBI-DCAQKATOSA-N Ala-Met-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N GKAZXNDATBWNBI-DCAQKATOSA-N 0.000 description 2
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 2
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 2
- QPOARHANPULOTM-GMOBBJLQSA-N Arg-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N QPOARHANPULOTM-GMOBBJLQSA-N 0.000 description 2
- OTCJMMRQBVDQRK-DCAQKATOSA-N Arg-Asp-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OTCJMMRQBVDQRK-DCAQKATOSA-N 0.000 description 2
- GOWZVQXTHUCNSQ-NHCYSSNCSA-N Arg-Glu-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GOWZVQXTHUCNSQ-NHCYSSNCSA-N 0.000 description 2
- AUFHLLPVPSMEOG-YUMQZZPRSA-N Arg-Gly-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AUFHLLPVPSMEOG-YUMQZZPRSA-N 0.000 description 2
- YQGZIRIYGHNSQO-ZPFDUUQYSA-N Arg-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YQGZIRIYGHNSQO-ZPFDUUQYSA-N 0.000 description 2
- CFGHCPUPFHWMCM-FDARSICLSA-N Arg-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N CFGHCPUPFHWMCM-FDARSICLSA-N 0.000 description 2
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 2
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 2
- UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 2
- KSUALAGYYLQSHJ-RCWTZXSCSA-N Arg-Met-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KSUALAGYYLQSHJ-RCWTZXSCSA-N 0.000 description 2
- INXWADWANGLMPJ-JYJNAYRXSA-N Arg-Phe-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CC1=CC=CC=C1 INXWADWANGLMPJ-JYJNAYRXSA-N 0.000 description 2
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 2
- CGWVCWFQGXOUSJ-ULQDDVLXSA-N Arg-Tyr-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O CGWVCWFQGXOUSJ-ULQDDVLXSA-N 0.000 description 2
- MEFGKQUUYZOLHM-GMOBBJLQSA-N Asn-Arg-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MEFGKQUUYZOLHM-GMOBBJLQSA-N 0.000 description 2
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 2
- PCKRJVZAQZWNKM-WHFBIAKZSA-N Asn-Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O PCKRJVZAQZWNKM-WHFBIAKZSA-N 0.000 description 2
- OPEPUCYIGFEGSW-WDSKDSINSA-N Asn-Gly-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OPEPUCYIGFEGSW-WDSKDSINSA-N 0.000 description 2
- XLHLPYFMXGOASD-CIUDSAMLSA-N Asn-His-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N XLHLPYFMXGOASD-CIUDSAMLSA-N 0.000 description 2
- JLNFZLNDHONLND-GARJFASQSA-N Asn-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N JLNFZLNDHONLND-GARJFASQSA-N 0.000 description 2
- ZYPWIUFLYMQZBS-SRVKXCTJSA-N Asn-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ZYPWIUFLYMQZBS-SRVKXCTJSA-N 0.000 description 2
- HPNDKUOLNRVRAY-BIIVOSGPSA-N Asn-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N)C(=O)O HPNDKUOLNRVRAY-BIIVOSGPSA-N 0.000 description 2
- LKIYSIYBKYLKPU-BIIVOSGPSA-N Asp-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O LKIYSIYBKYLKPU-BIIVOSGPSA-N 0.000 description 2
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 2
- ZEDBMCPXPIYJLW-XHNCKOQMSA-N Asp-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O ZEDBMCPXPIYJLW-XHNCKOQMSA-N 0.000 description 2
- JUWZKMBALYLZCK-WHFBIAKZSA-N Asp-Gly-Asn Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O JUWZKMBALYLZCK-WHFBIAKZSA-N 0.000 description 2
- VWWAFGHMPWBKEP-GMOBBJLQSA-N Asp-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)N VWWAFGHMPWBKEP-GMOBBJLQSA-N 0.000 description 2
- IDDMGSKZQDEDGA-SRVKXCTJSA-N Asp-Phe-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 IDDMGSKZQDEDGA-SRVKXCTJSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- WVJHEDOLHPZLRV-CIUDSAMLSA-N Cys-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N WVJHEDOLHPZLRV-CIUDSAMLSA-N 0.000 description 2
- LHMSYHSAAJOEBL-CIUDSAMLSA-N Cys-Lys-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O LHMSYHSAAJOEBL-CIUDSAMLSA-N 0.000 description 2
- MQQLYEHXSBJTRK-FXQIFTODSA-N Cys-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N MQQLYEHXSBJTRK-FXQIFTODSA-N 0.000 description 2
- QYTKAVBFRUGYAU-ACZMJKKPSA-N Gln-Asp-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QYTKAVBFRUGYAU-ACZMJKKPSA-N 0.000 description 2
- SFAFZYYMAWOCIC-KKUMJFAQSA-N Gln-Phe-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N SFAFZYYMAWOCIC-KKUMJFAQSA-N 0.000 description 2
- QBEWLBKBGXVVPD-RYUDHWBXSA-N Gln-Phe-Gly Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N QBEWLBKBGXVVPD-RYUDHWBXSA-N 0.000 description 2
- WLRYGVYQFXRJDA-DCAQKATOSA-N Gln-Pro-Pro Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 WLRYGVYQFXRJDA-DCAQKATOSA-N 0.000 description 2
- SDSMVVSHLAAOJL-UKJIMTQDSA-N Gln-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N SDSMVVSHLAAOJL-UKJIMTQDSA-N 0.000 description 2
- IRDASPPCLZIERZ-XHNCKOQMSA-N Glu-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N IRDASPPCLZIERZ-XHNCKOQMSA-N 0.000 description 2
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 2
- QPRZKNOOOBWXSU-CIUDSAMLSA-N Glu-Asp-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N QPRZKNOOOBWXSU-CIUDSAMLSA-N 0.000 description 2
- JPHYJQHPILOKHC-ACZMJKKPSA-N Glu-Asp-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O JPHYJQHPILOKHC-ACZMJKKPSA-N 0.000 description 2
- RTOOAKXIJADOLL-GUBZILKMSA-N Glu-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N RTOOAKXIJADOLL-GUBZILKMSA-N 0.000 description 2
- PXHABOCPJVTGEK-BQBZGAKWSA-N Glu-Gln-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O PXHABOCPJVTGEK-BQBZGAKWSA-N 0.000 description 2
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 2
- JYXKPJVDCAWMDG-ZPFDUUQYSA-N Glu-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)N JYXKPJVDCAWMDG-ZPFDUUQYSA-N 0.000 description 2
- KIEICAOUSNYOLM-NRPADANISA-N Glu-Val-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KIEICAOUSNYOLM-NRPADANISA-N 0.000 description 2
- KFMBRBPXHVMDFN-UWVGGRQHSA-N Gly-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCNC(N)=N KFMBRBPXHVMDFN-UWVGGRQHSA-N 0.000 description 2
- GWCRIHNSVMOBEQ-BQBZGAKWSA-N Gly-Arg-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O GWCRIHNSVMOBEQ-BQBZGAKWSA-N 0.000 description 2
- SABZDFAAOJATBR-QWRGUYRKSA-N Gly-Cys-Phe Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SABZDFAAOJATBR-QWRGUYRKSA-N 0.000 description 2
- PTIIBFKSLCYQBO-NHCYSSNCSA-N Gly-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN PTIIBFKSLCYQBO-NHCYSSNCSA-N 0.000 description 2
- GAFKBWKVXNERFA-QWRGUYRKSA-N Gly-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 GAFKBWKVXNERFA-QWRGUYRKSA-N 0.000 description 2
- CSMYMGFCEJWALV-WDSKDSINSA-N Gly-Ser-Gln Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(N)=O CSMYMGFCEJWALV-WDSKDSINSA-N 0.000 description 2
- SOFSRBYHDINIRG-QTKMDUPCSA-N His-Arg-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CN=CN1)N)O SOFSRBYHDINIRG-QTKMDUPCSA-N 0.000 description 2
- WJGSTIMGSIWHJX-HVTMNAMFSA-N His-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N WJGSTIMGSIWHJX-HVTMNAMFSA-N 0.000 description 2
- RNMNYMDTESKEAJ-KKUMJFAQSA-N His-Leu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 RNMNYMDTESKEAJ-KKUMJFAQSA-N 0.000 description 2
- LNDVNHOSZQPJGI-AVGNSLFASA-N His-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CN=CN1 LNDVNHOSZQPJGI-AVGNSLFASA-N 0.000 description 2
- VIJMRAIWYWRXSR-CIUDSAMLSA-N His-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 VIJMRAIWYWRXSR-CIUDSAMLSA-N 0.000 description 2
- RGSOCXHDOPQREB-ZPFDUUQYSA-N Ile-Asp-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N RGSOCXHDOPQREB-ZPFDUUQYSA-N 0.000 description 2
- ZDNORQNHCJUVOV-KBIXCLLPSA-N Ile-Gln-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O ZDNORQNHCJUVOV-KBIXCLLPSA-N 0.000 description 2
- HTDRTKMNJRRYOJ-SIUGBPQLSA-N Ile-Gln-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HTDRTKMNJRRYOJ-SIUGBPQLSA-N 0.000 description 2
- KIMHKBDJQQYLHU-PEFMBERDSA-N Ile-Glu-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KIMHKBDJQQYLHU-PEFMBERDSA-N 0.000 description 2
- OUUCIIJSBIBCHB-ZPFDUUQYSA-N Ile-Leu-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O OUUCIIJSBIBCHB-ZPFDUUQYSA-N 0.000 description 2
- PARSHQDZROHERM-NHCYSSNCSA-N Ile-Lys-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)N PARSHQDZROHERM-NHCYSSNCSA-N 0.000 description 2
- FFAUOCITXBMRBT-YTFOTSKYSA-N Ile-Lys-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FFAUOCITXBMRBT-YTFOTSKYSA-N 0.000 description 2
- GLYJPWIRLBAIJH-UHFFFAOYSA-N Ile-Lys-Pro Natural products CCC(C)C(N)C(=O)NC(CCCCN)C(=O)N1CCCC1C(O)=O GLYJPWIRLBAIJH-UHFFFAOYSA-N 0.000 description 2
- IITVUURPOYGCTD-NAKRPEOUSA-N Ile-Pro-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IITVUURPOYGCTD-NAKRPEOUSA-N 0.000 description 2
- SVZFKLBRCYCIIY-CYDGBPFRSA-N Ile-Pro-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SVZFKLBRCYCIIY-CYDGBPFRSA-N 0.000 description 2
- VISRCHQHQCLODA-NAKRPEOUSA-N Ile-Pro-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N VISRCHQHQCLODA-NAKRPEOUSA-N 0.000 description 2
- MLSUZXHSNRBDCI-CYDGBPFRSA-N Ile-Pro-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)O)N MLSUZXHSNRBDCI-CYDGBPFRSA-N 0.000 description 2
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 2
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 2
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 2
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 2
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 2
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 2
- CIVKXGPFXDIQBV-WDCWCFNPSA-N Leu-Gln-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CIVKXGPFXDIQBV-WDCWCFNPSA-N 0.000 description 2
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 2
- KEVYYIMVELOXCT-KBPBESRZSA-N Leu-Gly-Phe Chemical compound CC(C)C[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 KEVYYIMVELOXCT-KBPBESRZSA-N 0.000 description 2
- ORWTWZXGDBYVCP-BJDJZHNGSA-N Leu-Ile-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC(C)C ORWTWZXGDBYVCP-BJDJZHNGSA-N 0.000 description 2
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 2
- ZGUMORRUBUCXEH-AVGNSLFASA-N Leu-Lys-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZGUMORRUBUCXEH-AVGNSLFASA-N 0.000 description 2
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 2
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 description 2
- BMVFXOQHDQZAQU-DCAQKATOSA-N Leu-Pro-Asp Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N BMVFXOQHDQZAQU-DCAQKATOSA-N 0.000 description 2
- KWLWZYMNUZJKMZ-IHRRRGAJSA-N Leu-Pro-Leu Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O KWLWZYMNUZJKMZ-IHRRRGAJSA-N 0.000 description 2
- XXXXOVFBXRERQL-ULQDDVLXSA-N Leu-Pro-Phe Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XXXXOVFBXRERQL-ULQDDVLXSA-N 0.000 description 2
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 2
- 229910009891 LiAc Inorganic materials 0.000 description 2
- YKIRNDPUWONXQN-GUBZILKMSA-N Lys-Asn-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKIRNDPUWONXQN-GUBZILKMSA-N 0.000 description 2
- PXHCFKXNSBJSTQ-KKUMJFAQSA-N Lys-Asn-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N)O PXHCFKXNSBJSTQ-KKUMJFAQSA-N 0.000 description 2
- IWWMPCPLFXFBAF-SRVKXCTJSA-N Lys-Asp-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O IWWMPCPLFXFBAF-SRVKXCTJSA-N 0.000 description 2
- WTZUSCUIVPVCRH-SRVKXCTJSA-N Lys-Gln-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N WTZUSCUIVPVCRH-SRVKXCTJSA-N 0.000 description 2
- GGNOBVSOZPHLCE-GUBZILKMSA-N Lys-Gln-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GGNOBVSOZPHLCE-GUBZILKMSA-N 0.000 description 2
- VSRXPEHZMHSFKU-IUCAKERBSA-N Lys-Gln-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O VSRXPEHZMHSFKU-IUCAKERBSA-N 0.000 description 2
- DAOSYIZXRCOKII-SRVKXCTJSA-N Lys-His-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O DAOSYIZXRCOKII-SRVKXCTJSA-N 0.000 description 2
- MXMDJEJWERYPMO-XUXIUFHCSA-N Lys-Ile-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MXMDJEJWERYPMO-XUXIUFHCSA-N 0.000 description 2
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 2
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 2
- YUAXTFMFMOIMAM-QWRGUYRKSA-N Lys-Lys-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O YUAXTFMFMOIMAM-QWRGUYRKSA-N 0.000 description 2
- QBHGXFQJFPWJIH-XUXIUFHCSA-N Lys-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN QBHGXFQJFPWJIH-XUXIUFHCSA-N 0.000 description 2
- RPWTZTBIFGENIA-VOAKCMCISA-N Lys-Thr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RPWTZTBIFGENIA-VOAKCMCISA-N 0.000 description 2
- VHGIWFGJIHTASW-FXQIFTODSA-N Met-Ala-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O VHGIWFGJIHTASW-FXQIFTODSA-N 0.000 description 2
- OIFHHODAXVWKJN-ULQDDVLXSA-N Met-Phe-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 OIFHHODAXVWKJN-ULQDDVLXSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 2
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- DPUOLKQSMYLRDR-UBHSHLNASA-N Phe-Arg-Ala Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 DPUOLKQSMYLRDR-UBHSHLNASA-N 0.000 description 2
- DJPXNKUDJKGQEE-BZSNNMDCSA-N Phe-Asp-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DJPXNKUDJKGQEE-BZSNNMDCSA-N 0.000 description 2
- MIICYIIBVYQNKE-QEWYBTABSA-N Phe-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N MIICYIIBVYQNKE-QEWYBTABSA-N 0.000 description 2
- QRUOLOPKCOEZKU-HJWJTTGWSA-N Phe-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CC=CC=C1)N QRUOLOPKCOEZKU-HJWJTTGWSA-N 0.000 description 2
- MWQXFDIQXIXPMS-UNQGMJICSA-N Phe-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O MWQXFDIQXIXPMS-UNQGMJICSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- AQGUSRZKDZYGGV-GMOBBJLQSA-N Pro-Ile-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O AQGUSRZKDZYGGV-GMOBBJLQSA-N 0.000 description 2
- BWCZJGJKOFUUCN-ZPFDUUQYSA-N Pro-Ile-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O BWCZJGJKOFUUCN-ZPFDUUQYSA-N 0.000 description 2
- SUENWIFTSTWUKD-AVGNSLFASA-N Pro-Leu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SUENWIFTSTWUKD-AVGNSLFASA-N 0.000 description 2
- SMFQZMGHCODUPQ-ULQDDVLXSA-N Pro-Lys-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SMFQZMGHCODUPQ-ULQDDVLXSA-N 0.000 description 2
- YHUBAXGAAYULJY-ULQDDVLXSA-N Pro-Tyr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O YHUBAXGAAYULJY-ULQDDVLXSA-N 0.000 description 2
- VMVNCJDKFOQOHM-GUBZILKMSA-N Ser-Gln-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N VMVNCJDKFOQOHM-GUBZILKMSA-N 0.000 description 2
- PVDTYLHUWAEYGY-CIUDSAMLSA-N Ser-Glu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PVDTYLHUWAEYGY-CIUDSAMLSA-N 0.000 description 2
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 2
- LQESNKGTTNHZPZ-GHCJXIJMSA-N Ser-Ile-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O LQESNKGTTNHZPZ-GHCJXIJMSA-N 0.000 description 2
- JIPVNVNKXJLFJF-BJDJZHNGSA-N Ser-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N JIPVNVNKXJLFJF-BJDJZHNGSA-N 0.000 description 2
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 2
- LLSLRQOEAFCZLW-NRPADANISA-N Ser-Val-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LLSLRQOEAFCZLW-NRPADANISA-N 0.000 description 2
- LMMDEZPNUTZJAY-GCJQMDKQSA-N Thr-Asp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O LMMDEZPNUTZJAY-GCJQMDKQSA-N 0.000 description 2
- NZRUWPIYECBYRK-HTUGSXCWSA-N Thr-Phe-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O NZRUWPIYECBYRK-HTUGSXCWSA-N 0.000 description 2
- NHQVWACSJZJCGJ-FLBSBUHZSA-N Thr-Thr-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NHQVWACSJZJCGJ-FLBSBUHZSA-N 0.000 description 2
- OQMQBYOEAHVCGD-GQGQLFGLSA-N Trp-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N OQMQBYOEAHVCGD-GQGQLFGLSA-N 0.000 description 2
- NLLARHRWSFNEMH-NUTKFTJISA-N Trp-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N NLLARHRWSFNEMH-NUTKFTJISA-N 0.000 description 2
- QKXAEWMHAAVVGS-KKUMJFAQSA-N Tyr-Pro-Glu Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O QKXAEWMHAAVVGS-KKUMJFAQSA-N 0.000 description 2
- SYFHQHYTNCQCCN-MELADBBJSA-N Tyr-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O SYFHQHYTNCQCCN-MELADBBJSA-N 0.000 description 2
- HZDQUVQEVVYDDA-ACRUOGEOSA-N Tyr-Tyr-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HZDQUVQEVVYDDA-ACRUOGEOSA-N 0.000 description 2
- UEOOXDLMQZBPFR-ZKWXMUAHSA-N Val-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N UEOOXDLMQZBPFR-ZKWXMUAHSA-N 0.000 description 2
- HURRXSNHCCSJHA-AUTRQRHGSA-N Val-Gln-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N HURRXSNHCCSJHA-AUTRQRHGSA-N 0.000 description 2
- UZDHNIJRRTUKKC-DLOVCJGASA-N Val-Gln-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N UZDHNIJRRTUKKC-DLOVCJGASA-N 0.000 description 2
- WMRWZYSRQUORHJ-YDHLFZDLSA-N Val-Phe-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WMRWZYSRQUORHJ-YDHLFZDLSA-N 0.000 description 2
- FMQGYTMERWBMSI-HJWJTTGWSA-N Val-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N FMQGYTMERWBMSI-HJWJTTGWSA-N 0.000 description 2
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 2
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 2
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 108010038633 aspartylglutamate Proteins 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 108010051673 leucyl-glycyl-phenylalanine Proteins 0.000 description 2
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 2
- 108010000761 leucylarginine Proteins 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010064235 lysylglycine Proteins 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 108010090894 prolylleucine Proteins 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 108010051110 tyrosyl-lysine Proteins 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- SACHLUOUHCVIKI-GMOBBJLQSA-N Ile-Arg-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N SACHLUOUHCVIKI-GMOBBJLQSA-N 0.000 description 1
- NULSANWBUWLTKN-NAKRPEOUSA-N Ile-Arg-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N NULSANWBUWLTKN-NAKRPEOUSA-N 0.000 description 1
- 241001469893 Oxyzygonectes dovii Species 0.000 description 1
- MECSIDWUTYRHRJ-KKUMJFAQSA-N Phe-Asn-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O MECSIDWUTYRHRJ-KKUMJFAQSA-N 0.000 description 1
- ZYNBEWGJFXTBDU-ACRUOGEOSA-N Phe-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)N ZYNBEWGJFXTBDU-ACRUOGEOSA-N 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 101150102092 ccdB gene Proteins 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010359 gene isolation Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开了一种具有高催化活性的Ppmar1转座酶D332S突变体,所述的Ppmar1转座酶D332S突变体的氨基酸序列如SEQ ID NO.1所示。编码所述Ppmar1转座酶D332S突变体的基因的核苷酸序列如SEQ ID NO.2所示。是将野生型Ppmar1转座酶332位置上的天冬氨酸突变为丝氨酸。该Ppmar1转座酶D332S突变体催化转座子转座的活性是野生型转座酶的活性的2.56倍,为利用MLE转座子开发基因标签奠定了基础,为后基因组时代大规模分离和标记基因,研究基因的功能提供了新工具。The invention discloses a Ppmar1 transposase D332S mutant with high catalytic activity, and the amino acid sequence of the Ppmar1 transposase D332S mutant is shown in SEQ ID NO.1. The nucleotide sequence of the gene encoding the Ppmar1 transposase D332S mutant is shown in SEQ ID NO.2. The aspartic acid at position 332 of the wild-type Ppmar1 transposase was mutated to serine. The activity of the Ppmar1 transposase D332S mutant to catalyze transposon transposition is 2.56 times that of the wild-type transposase, laying a foundation for the development of gene tags using MLE transposons for large-scale isolation and tagging in the post-genomic era Genes, provide new tools to study the function of genes.
Description
技术领域technical field
本发明属于生物技术领域,具体涉及一种具有高催化活性的Ppmar1转座酶D332S突变体及其应用。The invention belongs to the field of biotechnology, in particular to a Ppmar1 transposase D332S mutant with high catalytic activity and an application thereof.
背景技术Background technique
转座子(transposon)是指在基因组上能从一个位点转移到另一个位点的一段DNA序列。自20世纪40年代美国遗传学家McClintock首先在玉米中发现转座子(Ac/Ds)以来,科学家们发现了多种类型的转座子,它们广泛存在于细菌、酵母和高等动植物中。随着人们在分子水平上对转座子结构和功能认识的不断深化,一些转座子已被改造为基因标签应用于基因分析,并逐渐成为大规模分离基因的重要手段之一。A transposon is a DNA sequence that can be transferred from one site to another on the genome. Since the American geneticist McClintock first discovered transposons (Ac/Ds) in maize in the 1940s, scientists have discovered many types of transposons, which are widely found in bacteria, yeast, and higher plants and animals. With the deepening of the understanding of the structure and function of transposons at the molecular level, some transposons have been transformed into gene tags for gene analysis, and have gradually become one of the important methods for large-scale gene isolation.
Mariner-Like转座子(Mariner-Like Elements,MLE)是转座子中一个重要家族,最早是在研究毛里塔尼亚果蝇(Drosophila mauristiana)白眼基因的一个不稳定突变时发现的。此后在其他动物以及植物基因组中也发现了大量MLE转座子的存在。与其它转座子相比较,MLE转座子具有结构简单、异源转座率高、在基因组插入位点接近随机等特点,在开发基因标签,分离基因,研究基因功能上,远远优于其他转座子。Mariner-Like Elements (MLE) is an important family of transposons, which was first discovered in the study of an unstable mutation in the white-eye gene of Drosophila mauristiana. Since then, a large number of MLE transposons have also been found in other animal and plant genomes. Compared with other transposons, MLE transposons have the characteristics of simple structure, high heterologous transposition rate, and close to random insertion sites in the genome. other transposons.
MLE转座子由两端反向重复序列(Terminal Inverted Repeats,TIRs)和编码转座酶的基因组成,转座酶负责催化转座子转座,因此转座酶的活性是影响转座子的转座频率的主要因素。然而自然界分离的MLE转座酶由于在进化过程中“垂直失活”效应积累了或多或少的突变,部分或全部丧失了催化转座能力,成为低活性或非活性的转座酶,严重影响了MLE转座子的应用,因此人工构建高活性的转座酶就显得十分重要。The MLE transposon is composed of Terminal Inverted Repeats (TIRs) and a gene encoding a transposase. The transposase is responsible for catalyzing the transposition of the transposon, so the activity of the transposase affects the transposon. Major factor in transposition frequency. However, the MLE transposase isolated in nature has accumulated more or less mutations due to the "vertical inactivation" effect in the evolution process, partially or completely lost the ability to catalyze transposition, and become a low-activity or inactive transposase. It affects the application of MLE transposons, so it is very important to artificially construct highly active transposases.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一种具有高催化活性的Ppmar1转座酶D332S突变体及其应用,解决了现有自然界分离的MLE转座酶催化活性较低或者不具备催化活性的问题。The purpose of the present invention is to provide a Ppmar1 transposase D332S mutant with high catalytic activity and its application, which solve the problem of low catalytic activity or no catalytic activity of the existing MLE transposase isolated from nature.
本发明提供了一种具有高催化活性的Ppmar1转座酶D332S突变体,所述的Ppmar1转座酶D332S突变体的氨基酸序列如SEQ ID NO.1所示。The present invention provides a Ppmar1 transposase D332S mutant with high catalytic activity, and the amino acid sequence of the Ppmar1 transposase D332S mutant is shown in SEQ ID NO.1.
本发明还提供了一种编码所述Ppmar1转座酶D332S突变体的基因,编码所述Ppmar1转座酶D332S突变体的基因的核苷酸序列如SEQ ID NO.2所示。The present invention also provides a gene encoding the Ppmar1 transposase D332S mutant, and the nucleotide sequence of the gene encoding the Ppmar1 transposase D332S mutant is shown in SEQ ID NO. 2.
本发明还提供了一种重组质粒,所述重组质粒携带有编码所述Ppmar1转座酶D332S突变体的基因。The present invention also provides a recombinant plasmid carrying a gene encoding the Ppmar1 transposase D332S mutant.
本发明还提供了一种工程菌株,所述工程菌株携带有上述重组质粒。The present invention also provides an engineering strain carrying the above-mentioned recombinant plasmid.
本发明还提供了一种具有高催化活性的Ppmar1转座酶D332S突变体在构建酵母突变体中的应用。The invention also provides the application of a Ppmar1 transposase D332S mutant with high catalytic activity in constructing a yeast mutant.
与现有技术相比,本发明提供的一种具有高催化活性的Ppmar1转座酶D332S突变体,具有以下有益效果:Compared with the prior art, the Ppmar1 transposase D332S mutant with high catalytic activity provided by the present invention has the following beneficial effects:
本发明从毛竹中克隆到的活性转座酶,对其进行人工改造之后获得较高活性的MLE转座酶突变体(Ppmar1转座酶D332S突变体),Ppmar1转座酶D332S突变体催化转座子转座的活性是野生型转座酶的活性的2.56倍,为利用MLE转座子开发基因标签奠定了基础,为后基因组时代大规模分离和标记基因,研究基因的功能提供了新工具。The active transposase cloned from Phyllostachys edulis in the present invention is artificially transformed to obtain a highly active MLE transposase mutant (Ppmar1 transposase D332S mutant), and the Ppmar1 transposase D332S mutant catalyzes transposition The activity of the subtransposase is 2.56 times that of the wild-type transposase, which lays the foundation for the development of gene tags using MLE transposons, and provides a new tool for large-scale isolation and tagging of genes in the post-genome era and studying the function of genes.
具体实施方式Detailed ways
下面结合具体实施方式对本发明进行详细说明,但应当理解本发明的保护范围并不受具体实施方式的限制。下列实施例中未注明具体条件的试验方法,通常按照常规条件操作,如Sambrook等主编的《分子克隆实验指南》中所述条件,或按照试剂盒陈述的步骤进行操作,由于不涉及发明点,故不对其步骤进行详细描述。The present invention will be described in detail below with reference to the specific embodiments, but it should be understood that the protection scope of the present invention is not limited by the specific embodiments. The test methods without specific conditions in the following examples are usually operated under conventional conditions, such as the conditions described in the "Molecular Cloning Experiment Guide" edited by Sambrook et al., or according to the steps stated in the kit, because the invention is not involved. , so the steps are not described in detail.
当实施例给出数值范围时,应理解,除非本发明另有说明,每个数值范围的两个端点以及两个端点之间任何一个数值均可选用。除非另外定义,本发明中使用的所有技术和科学术语与本技术领域技术人员通常理解的意义相同。除实施例中使用的具体方法、设备、材料外,根据本技术领域的技术人员对现有技术的掌握及本发明的记载,还可以使用与本发明实施例中所述的方法、设备、材料相似或等同的现有技术的任何方法、设备和材料来实现本发明。When numerical ranges are given in the examples, it is to be understood that, unless otherwise indicated herein, both endpoints of each numerical range and any number between the two endpoints may be selected. Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as commonly understood by one of ordinary skill in the art. In addition to the specific methods, equipment and materials used in the embodiments, according to the mastery of the prior art by those skilled in the art and the description of the present invention, the methods, equipment and materials described in the embodiments of the present invention can also be used Any methods, devices and materials similar or equivalent to those of the prior art can be used to implement the present invention.
一、野生型MLE转座酶和去除转座酶的非自主性转座子的获得1. Acquisition of wild-type MLE transposase and transposase-removed non-autonomous transposons
步骤1.1,采集新鲜的毛竹叶片(Phyllostachyspubescens,采集于浙江农林大学植物园,北纬N30°15′14.67″东经E119°43′33.47″),利用CTAB法提取毛竹基因组DNA,根据MLE转座子TIR保守序列设计引物Ppmar1-5-3(Ppmar1-5-3的序列信息见表1),进行PCR扩增,得到MLE转座子扩增产物。Step 1.1, collect fresh bamboo leaves (Phyllostachyspubescens, collected in the Botanical Garden of Zhejiang Agriculture and Forestry University, N30°15′14.67″N latitude E119°43′33.47″E longitude E119°43′33.47″), use the CTAB method to extract the bamboo genomic DNA, according to the MLE transposon TIR conserved sequence The primer Ppmar1-5-3 was designed (see Table 1 for the sequence information of Ppmar1-5-3), and PCR amplification was performed to obtain the MLE transposon amplification product.
PCR扩增的体系为20μl,包括0.2μl rTaq Polymerase(5U/μl),1μl Ppmar1-5-3(10μmol/L),2μl 10×rTaq Buffer(Mg2+plus),1.6μl dNTP mix(2.5mmol/L),100ng毛竹基因组DNA,加无菌水补齐20μl。The PCR amplification system was 20 μl, including 0.2 μl rTaq Polymerase (5U/μl), 1 μl Ppmar1-5-3 (10 μmol/L), 2 μl 10×rTaq Buffer (Mg 2+ plus), 1.6 μl dNTP mix (2.5 mmol/L) /L), 100ng of Phyllostachys pubescens genomic DNA, add sterile water to make up 20μl.
PCR扩增的反应条件为:预变性94℃5min;变性94℃30s,60℃30s,延伸72℃40s,35个循环;72℃2min,4℃10min。The reaction conditions of PCR amplification were: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30s, 60°C for 30s, extension at 72°C for 40s, 35 cycles; 72°C for 2min, 4°C for 10min.
步骤1.2,扩增出序列后,采用TaKaRa公司pMDTM18-T Vector Cloning Kit试剂盒的方法将步骤1.1的MLE转座子扩增产物连接到pMD18-T载体,测序确认后,命名为Ppmar1转座子,Ppmar1转座子全长序列如SEQ ID NO.3所示。In step 1.2, after the sequence was amplified, the amplified product of the MLE transposon in step 1.1 was ligated to the pMD18-T vector using the method of TaKaRa company pMD TM 18-T Vector Cloning Kit. The transposon, the full-length sequence of the Ppmar1 transposon is shown in SEQ ID NO.3.
步骤1.3,采用QIAGEN公司的RNeasy Mini Kit试剂盒提取毛竹叶片RNA,通过Invitrogen公司的SuperScriptTM VILOTM cDNA Synthesis Kit试剂盒将RNA反转录为cDNA,根据Ppmar1转座酶序列设计一对引物PpTpase1-5和PpTpase1-3(PpTpase1-5和PpTpase1-3的序列信息见表1),进行PCR扩增,回收得到Ppmar1转座酶扩增产物,即为Ppmar1转座酶核苷酸序列。Step 1.3, using the RNeasy Mini Kit of QIAGEN company to extract the leaf RNA of Phyllostachys pubescens, reverse-transcribe the RNA into cDNA by the SuperScript TM VILO TM cDNA Synthesis Kit of Invitrogen company, and design a pair of primers PpTpase1- 5 and PpTpase1-3 (see Table 1 for the sequence information of PpTpase1-5 and PpTpase1-3), carry out PCR amplification, and recover the Ppmar1 transposase amplification product, which is the Ppmar1 transposase nucleotide sequence.
PCR扩增的体系为20μl,包括0.2μl rTaq Polymerase(5U/μl),0.5μl PpTpase1-5(10μmol/L),0.5μl PpTpase1-3(10μmol/L),2μl 10×rTaq Buffer(Mg2+plus),1.6μl dNTPmix(2.5mmol/L),10ng毛竹叶片cDNA,加无菌水补齐20μl。The PCR amplification system was 20 μl, including 0.2 μl rTaq Polymerase (5U/μl), 0.5 μl PpTpase1-5 (10 μmol/L), 0.5 μl PpTpase1-3 (10 μmol/L), 2 μl 10×rTaq Buffer (Mg 2+ plus), 1.6 μl of dNTPmix (2.5 mmol/L), 10 ng of Phyllostachys edulis leaf cDNA, and 20 μl of sterile water was added.
PCR扩增的反应条件为:预变性94℃5min;变性94℃30s,55℃30s,延伸72℃40s,35个循环;72℃2min,4℃10min。The reaction conditions of PCR amplification were: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30s, 55°C for 30s, extension at 72°C for 40s, 35 cycles; 72°C for 2min, 4°C for 10min.
步骤1.4,采用TaKaRa公司pMDTM18-T Vector Cloning Kit试剂盒的方法将步骤1.3的Ppmar1转座酶核苷酸序列连接到pMD18-T载体克隆,测序确认,Ppmar1转座酶核苷酸序列和相应的氨基酸序列分别如SEQ ID NO.4和SEQ ID NO.5所示。In step 1.4, the nucleotide sequence of the Ppmar1 transposase in step 1.3 was ligated into the pMD18-T vector clone using the method of the pMD TM 18-T Vector Cloning Kit of TaKaRa Company, and the nucleotide sequence of the Ppmar1 transposase was confirmed by sequencing. The corresponding amino acid sequences are shown in SEQ ID NO.4 and SEQ ID NO.5, respectively.
将含有Ppmar1转座子全长序列的pMD18-T载体用BseR I切除Ppmar1中间转座酶的大部分序列。The pMD18-T vector containing the full-length sequence of the Ppmar1 transposon was excised with BseR I for most of the sequence of the Ppmar1 intermediate transposase.
酶切体系为50μl,包括5μl 10×buffer,1μl BseR I(1U/μl),1μg质粒(含有Ppmar1全长序列的pMD18-T载体),加无菌水补齐50μl,37℃温浴6小时。回收质粒大片段,用T4 DNA Ligase将质粒大片段自连接,得到Ppmar1的非自主性转座子pMD18-T-Ppmar1-Tn(Tn表示非自主性转座子)。The digestion system was 50 μl, including 5 μl of 10×buffer, 1 μl of BseR I (1 U/μl), 1 μg of plasmid (pMD18-T vector containing the full-length sequence of Ppmar1), supplemented with 50 μl of sterile water, and incubated at 37°C for 6 hours. The large plasmid fragment was recovered and self-ligated with T 4 DNA Ligase to obtain a non-autonomous transposon of Ppmar1 pMD18-T-Ppmar1-Tn (Tn represents a non-autonomous transposon).
其中,自连接的体系为10μl,包括1μl 10×T4 DNA Ligase buffer,1μl T4 DNALigase(10U/μl),50ng质粒大片段,加无菌水补齐10μl,16℃温浴8小时。The self-ligation system was 10 μl, including 1 μl of 10×T4 DNA Ligase buffer, 1 μl of T4 DNA Ligase (10 U/μl), 50 ng of large plasmid fragment, supplemented with 10 μl of sterile water, and incubated at 16°C for 8 hours.
Ppmar1的非自主性转座子的序列如SEQ ID NO.6所示。The sequence of the non-autonomous transposon of Ppmar1 is shown in SEQ ID NO.6.
二、酵母转座表达载体的构建2. Construction of yeast transposition expression vector
步骤2.1,Ppmar1转座酶表达载体的构建Step 2.1, Construction of Ppmar1 Transposase Expression Vector
将步骤1.3的Ppmar1转座酶核苷酸序列经Not I和EcoR V双酶切,回收Ppmar1转座酶酶切产物的大片段;将pAG413-gal-ccdB载体经Not I和EcoR V双酶切,回收pAG413-gal-ccdB载体酶切产物的大片段;且Ppmar1转座酶核苷酸序列的双酶切体系、双酶切条件与pAG413-gal-ccdB载体的双酶切体系、双酶切条件均相同;The nucleotide sequence of the Ppmar1 transposase in step 1.3 was double digested by Not I and EcoR V, and the large fragment of the Ppmar1 transposase digested product was recovered; the pAG413-gal-ccdB vector was digested by Not I and EcoR V. , the large fragment of the pAG413-gal-ccdB vector digestion product was recovered; and the double digestion system and double digestion conditions of the Ppmar1 transposase nucleotide sequence were the same as the double digestion system and double digestion conditions of the pAG413-gal-ccdB vector. conditions are the same;
其中双酶切体系为50μl,包括5μl 10×buffer,1μl Not I(1U/μl),1μl EcoR(1U/μl),1μg质粒(Ppmar1转座酶核苷酸序列或者pAG413-gal-ccdB载体),加无菌水补齐50μl,双酶切条件为:37℃温浴6小时。The double-enzyme digestion system is 50μl, including 5μl 10×buffer, 1μl Not I (1U/μl), 1μl EcoR (1U/μl), 1μg plasmid (Ppmar1 transposase nucleotide sequence or pAG413-gal-ccdB vector) , add sterile water to make up 50 μl, and the double-enzyme digestion conditions are: 37 ℃ warm bath for 6 hours.
将Ppmar1转座酶酶切产物的大片段和pAG413-gal-ccdB载体酶切产物的大片段相连接;Connect the large fragment of the digested product of Ppmar1 transposase to the large fragment of the digested product of pAG413-gal-ccdB vector;
连接体系为10μl,包括1μl 10×T4 DNA Ligase buffer,1μl T4 DNA Ligase(10U/μl),50ng pAG413-gal-ccdB载体酶切产物的大片段,20ng Ppmar1转座酶酶切产物的大片段,加无菌水补齐10μl,16℃温浴8小时。The ligation system is 10μl, including 1μl 10×T4 DNA Ligase buffer, 1μl T4 DNA Ligase (10U/μl), 50ng large fragment of pAG413-gal-ccdB vector digested product, 20ng large fragment of Ppmar1 transposase digested product, Add sterile water to make up 10 μl, and incubate at 16°C for 8 hours.
此时完成了用Ppmar1转座酶核苷酸序列替换pAG413-gal-ccdB质粒中的ccdB核苷酸序列,得到重组质粒pAG413-gal-Tpase(Tpase表示转座酶);At this point, the ccdB nucleotide sequence in the pAG413-gal-ccdB plasmid was replaced with the Ppmar1 transposase nucleotide sequence to obtain the recombinant plasmid pAG413-gal-Tpase (Tpase represents transposase);
该重组质粒pAG413-gal-Tpase即为Ppmar1转座酶表达载体,其携带有编码所述Ppmar1转座酶的基因。该表达载体具有His(组氨酸)筛选标记,使导入pAG413-gal-Tpase载体的宿主能够缺乏His的缺失培养基上生长。The recombinant plasmid pAG413-gal-Tpase is the Ppmar1 transposase expression vector, which carries the gene encoding the Ppmar1 transposase. The expression vector has a His (histidine) selectable marker, which enables the host into which the pAG413-gal-Tpase vector is introduced to grow on a His-deficient medium.
步骤2.2,Ppmar1非自主转座子供体载体的构建Step 2.2, Construction of Ppmar1 Non-autonomous Transposon Donor Vector
以步骤1.4的Ppmar1的非自主性转座子pMD18-T-Ppmar1-Tn为模板,利用Ppmar1-5-3引物扩增Ppmar1的非自主性转座子,进行PCR扩增,得到Ppmar1的非自主性转座子扩增产物。Using the non-autonomous transposon of Ppmar1 pMD18-T-Ppmar1-Tn in step 1.4 as a template, the non-autonomous transposon of Ppmar1 was amplified by primers Ppmar1-5-3, and PCR amplification was performed to obtain the non-autonomous transposon of Ppmar1. Sexual transposon amplification products.
PCR扩增的体系为20μl,包括0.2μl rTaq Polymerase(5U/μl),1μl Ppmar1-5-3(10μmol/L),2μl 10×rTaq Buffer(Mg2+plus),1.6μl dNTP mix(2.5mmol/L),10ng pMD18-T-Ppmar1-Tn,加无菌水补齐20μl。The PCR amplification system was 20 μl, including 0.2 μl rTaq Polymerase (5U/μl), 1 μl Ppmar1-5-3 (10 μmol/L), 2 μl 10×rTaq Buffer (Mg 2+ plus), 1.6 μl dNTP mix (2.5 mmol/L) /L), 10ng pMD18-T-Ppmar1-Tn, add sterile water to make up 20μl.
PCR扩增的反应条件为:预变性94℃5min;变性94℃30s,60℃30s,延伸72℃40s,35个循环;72℃2min,4℃10min。The reaction conditions of PCR amplification were: pre-denaturation at 94 °C for 5 min; denaturation at 94 °C for 30 s, 60 °C for 30 s, extension at 72 °C for 40 s, 35 cycles; 72 °C for 2 min, 4 °C for 10 min.
同时,将载体pWL89a用XhoⅠ酶切(酶切位点位于ADE2基因内),回收载体pWL89a骨架。酶切体系为50μl,包括5μl 10×buffer,1μl XhoⅠ(1U/μl),1μg载体pWL89a,加无菌水补齐50μl,37℃温浴6小时。At the same time, the vector pWL89a was digested with XhoI (the enzyme cleavage site is located in the ADE2 gene), and the vector pWL89a backbone was recovered. The digestion system was 50 μl, including 5 μl of 10×buffer, 1 μl of XhoI (1 U/μl), 1 μg of vector pWL89a, supplemented with 50 μl of sterile water, and incubated at 37°C for 6 hours.
然后用In-Fusion Advantage PCR Cloning Kit(TaKaRa公司,日本)将Ppmar1的非自主性转座子扩增产物插入到载体pWL89a骨架的ADE2基因中,导致报告基因ADE2插入失活,得到pWL89a-Tn重组质粒,即为Ppmar1非自主转座子供体载体。若转座子发生转座从ADE2基因上离开,那么ADE2基因阅读框得到回复。该载体具有URA3筛选标记,使导入pWL89a-Tn的宿主能够在缺乏Ura(尿素)的缺失培养基上生长。Then, the non-autonomous transposon amplification product of Ppmar1 was inserted into the ADE2 gene of the vector pWL89a backbone using the In-Fusion Advantage PCR Cloning Kit (TaKaRa Company, Japan), resulting in the inactivation of the reporter gene ADE2 insertion to obtain pWL89a-Tn recombination The plasmid is the Ppmar1 non-autonomous transposon donor vector. If the transposon is transposed away from the ADE2 gene, the ADE2 gene reading frame is restored. This vector has a URA3 selectable marker that enables the host into which pWL89a-Tn has been introduced to grow on deletion medium lacking Ura (urea).
三、Ppmar1转座酶D332S突变体的获得Third, the acquisition of Ppmar1 transposase D332S mutant
将Ppmar1转座酶核苷酸序列与其他植物MLE转座酶的核苷酸序列进行同源性比对,选取Ppmar1转座酶核苷酸序列332位置上的天冬氨酸开展突变,计划将其突变为丝氨酸(D332S)。The nucleotide sequence of Ppmar1 transposase was compared with the nucleotide sequences of other plant MLE transposases, and the aspartic acid at position 332 of the nucleotide sequence of Ppmar1 transposase was selected for mutation. It was mutated to serine (D332S).
步骤3.1,根据QuikChangeTM Site-Directed Mutagenesis Kit(Stratagene公司,美国)试剂盒说明书,设计定点突变引物D332S-F和D332S-R(D332S-F和D332S-R的序列信息见表1),按照QuikChangeTM Site-Directed Mutagenesis Kit试剂盒方法,以步骤2.1的重组质粒pAG413-gal-Tpase为模板,利用PfuTurboTM DNA polymerase重新合成含有Ppmar1转座酶D332S突变体的质粒DNA;Step 3.1, design site-directed mutagenesis primers D332S-F and D332S-R (see Table 1 for the sequence information of D332S-F and D332S-R) according to the kit instructions of QuikChange TM Site-Directed Mutagenesis Kit (Stratagene, USA), according to QuikChange TM Site-Directed Mutagenesis Kit method, using the recombinant plasmid pAG413-gal-Tpase in step 2.1 as a template, using PfuTurbo TM DNA polymerase to re-synthesize plasmid DNA containing the Ppmar1 transposase D332S mutant;
步骤3.2,然后在合成的质粒DNA中加入2μL的Dpn I限制性内切酶,于37℃条件下反应5min,将原始模板序列彻底降解。将新合成的质粒DNA测序确认后得到Ppmar1转座酶D332S突变体;In step 3.2, 2 μL of Dpn I restriction endonuclease was added to the synthesized plasmid DNA, and the reaction was carried out at 37°C for 5 min to completely degrade the original template sequence. The newly synthesized plasmid DNA was sequenced to confirm the Ppmar1 transposase D332S mutant;
Ppmar1转座酶D332S突变体的氨基酸序列如SEQ ID NO.1所示,编码所述Ppmar1转座酶D332S突变体的基因的核苷酸序列如SEQ ID NO.2所示。The amino acid sequence of the Ppmar1 transposase D332S mutant is shown in SEQ ID NO. 1, and the nucleotide sequence of the gene encoding the Ppmar1 transposase D332S mutant is shown in SEQ ID NO. 2.
四、转座酶活性的检测4. Detection of transposase activity
实验组是将步骤3.1的含有Ppmar1转座酶D332S突变体的质粒DNA和步骤2.2的pWL89a-Tn重组质粒,用PEG/LiAc法共同转化到酵母中,用His/Ura双缺固体培养基上进行选择培养。用半乳糖诱导转座酶表达,促使非自主转座子发生转座。In the experimental group, the plasmid DNA containing the Ppmar1 transposase D332S mutant in step 3.1 and the pWL89a-Tn recombinant plasmid in step 2.2 were co-transformed into yeast by the PEG/LiAc method, and carried out on a His/Ura double-deficient solid medium. Choose to cultivate. Induction of transposase expression with galactose promotes transposition of non-autonomous transposons.
以野生型Ppmar1转座酶为对照组,步骤2.1的带有野生型的Ppmar1转座酶的重组质粒pAG413-gal-Tpase和步骤2.2的pWL89a-Tn重组质粒,用PEG/LiAc法共同转化到酵母中,用His/Ura双缺固体培养基上进行选择培养。用半乳糖诱导转座酶表达,促使非自主转座子发生转座。Taking the wild-type Ppmar1 transposase as the control group, the recombinant plasmid pAG413-gal-Tpase with the wild-type Ppmar1 transposase in step 2.1 and the pWL89a-Tn recombinant plasmid in step 2.2 were co-transformed into yeast by PEG/LiAc method , using His/Ura double-deficient solid medium for selective culture. Induction of transposase expression with galactose promotes transposition of non-autonomous transposons.
实验组和对照组的经诱导培养的酵母用缺失His/Ura/Ade固体培养基上进行选择培养,计算培养基上长出的酵母菌斑。如果转座发生,pWL89a-Tn重组质粒上的ADE2基因就能表达,因此阳性酵母株能够在缺乏腺嘌呤的培养基上生长。The induced cultured yeasts of the experimental group and the control group were selected and cultured on the solid medium lacking His/Ura/Ade, and the yeast plaques grown on the medium were counted. If transposition occurs, the ADE2 gene on the pWL89a-Tn recombinant plasmid can be expressed, so positive yeast strains can grow on adenine-deficient medium.
以野生型Ppmar1转座酶为对照,比较转化有Ppmar1转座酶D332S突变体的酵母菌落数目,筛选出较高活性的转座酶突变株,结果如表2所示。Using the wild-type Ppmar1 transposase as a control, the number of yeast colonies transformed with the Ppmar1 transposase D332S mutant was compared, and the transposase mutant with higher activity was screened. The results are shown in Table 2.
由表2可知,野生型Ppmar1转座酶的阳性酵母菌落数量明显小于Ppmar1转座酶D332S突变体,且Ppmar1转座酶D332S突变体催化转座能力提高到原来的256%。这个高活性人工改造的Ppmar1转座酶D332S突变体将为利用Ppmar1转座子开发基因标签奠定了重要基础。It can be seen from Table 2 that the number of positive yeast colonies of the wild-type Ppmar1 transposase is significantly smaller than that of the Ppmar1 transposase D332S mutant, and the catalytic transposition ability of the Ppmar1 transposase D332S mutant is increased to 256% of the original. This highly active engineered Ppmar1 transposase D332S mutant will lay an important foundation for the development of gene tags using Ppmar1 transposons.
表1本发明应用的引物序列Table 1 Primer sequences used in the present invention
表2不同转座酶诱导的阳性酵母菌落数量和催化活性Table 2 The number and catalytic activity of positive yeast colonies induced by different transposases
尽管已描述了本发明的优选实施例,但本领域内的技术人员一旦得知了基本创造性概念,则可对这些实施例作出另外的变更和修改。所以,所附权利要求意欲解释为包括优选实施例以及落入本发明范围的所有变更和修改。Although preferred embodiments of the present invention have been described, additional changes and modifications to these embodiments may occur to those skilled in the art once the basic inventive concepts are known. Therefore, the appended claims are intended to be construed to include the preferred embodiment and all changes and modifications that fall within the scope of the present invention.
显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit and scope of the invention. Thus, provided that these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
序列表sequence listing
<110> 浙江农林大学<110> Zhejiang Agriculture and Forestry University
<120> 一种具有高催化活性的Ppmar1转座酶D332S突变体及其应用<120> A Ppmar1 transposase D332S mutant with high catalytic activity and its application
<160> 6<160> 6
<170> PatentIn version 3.3<170> PatentIn version 3.3
<210> 1<210> 1
<211> 499<211> 499
<212> PRT<212> PRT
<213> 人工序列<213> Artificial sequences
<400> 1<400> 1
Met Ala Asp Pro Ile Asp Ser Gly Phe Asp Leu Asn Val Arg Leu GluMet Ala Asp Pro Ile Asp Ser Gly Phe Asp Leu Asn Val Arg Leu Glu
1 5 10 151 5 10 15
Glu Asp Asp Asp Gly Asn Leu Pro Phe Asp Leu Asn Glu Pro Ile LeuGlu Asp Asp Asp Gly Asn Leu Pro Phe Asp Leu Asn Glu Pro Ile Leu
20 25 30 20 25 30
Glu Asp His Asn Asn Gly Ile Asp Leu Asn Leu Pro Leu Asp Glu PheGlu Asp His Asn Asn Gly Ile Asp Leu Asn Leu Pro Leu Asp Glu Phe
35 40 45 35 40 45
Gly Ala Val Asp Phe Asp Tyr Val Gln Asn Leu Ala Glu Gln Asp ValGly Ala Val Asp Phe Asp Tyr Val Gln Asn Leu Ala Glu Gln Asp Val
50 55 60 50 55 60
Glu Ala Pro Val Gln Val His Pro Pro Lys His Asp Tyr Pro Glu HisGlu Ala Pro Val Gln Val His Pro Pro Lys His Asp Tyr Pro Glu His
65 70 75 8065 70 75 80
Val Arg Lys Leu Val Tyr Gln Ala Leu Leu Met Arg Ser Lys Asn GlyVal Arg Lys Leu Val Tyr Gln Ala Leu Leu Met Arg Ser Lys Asn Gly
85 90 95 85 90 95
Lys Leu Gly Asn His Asp Thr Thr Ile Val Ser Ser Gln Phe Gly ValLys Leu Gly Asn His Asp Thr Thr Ile Val Ser Ser Gln Phe Gly Val
100 105 110 100 105 110
Lys Ile Arg Ser Val Gln Arg Ile Trp Lys Gln Gly Lys Asn Gln LeuLys Ile Arg Ser Val Gln Arg Ile Trp Lys Gln Gly Lys Asn Gln Leu
115 120 125 115 120 125
Ala Gln Asn Ile Pro Val Val Val Ala Asn Leu Lys Lys Gly Arg SerAla Gln Asn Ile Pro Val Val Val Val Ala Asn Leu Lys Lys Gly Arg Ser
130 135 140 130 135 140
Gly Arg Lys Ala Thr Pro Leu Asp Leu Glu Gln Leu Arg Asn Ile ProGly Arg Lys Ala Thr Pro Leu Asp Leu Glu Gln Leu Arg Asn Ile Pro
145 150 155 160145 150 155 160
Leu Lys Gln Arg Met Thr Ile Glu Asp Val Ser Ser Arg Leu Gly IleLeu Lys Gln Arg Met Thr Ile Glu Asp Val Ser Ser Arg Leu Gly Ile
165 170 175 165 170 175
Ser Lys Ser Arg Ile Gln Arg Tyr Leu Lys Lys Gly Leu Leu Arg ArgSer Lys Ser Arg Ile Gln Arg Tyr Leu Lys Lys Gly Leu Leu Arg Arg
180 185 190 180 185 190
His Ser Ser Ser Ile Lys Pro Tyr Leu Thr Asp Ala Asn Lys Lys ThrHis Ser Ser Ser Ile Lys Pro Tyr Leu Thr Asp Ala Asn Lys Lys Thr
195 200 205 195 200 205
Arg Leu Lys Trp Cys Ile Asp Met Ile Glu Gln Gly Leu Val Asp AspArg Leu Lys Trp Cys Ile Asp Met Ile Glu Gln Gly Leu Val Asp Asp
210 215 220 210 215 220
Pro Lys Phe Arg Asp Leu Phe Asp Phe Val Phe Ile Asp Glu Lys TrpPro Lys Phe Arg Asp Leu Phe Asp Phe Val Phe Ile Asp Glu Lys Trp
225 230 235 240225 230 235 240
Phe Asn Leu Ser Gln Lys Ser Glu Arg Tyr Tyr Leu Leu Pro Asp GluPhe Asn Leu Ser Gln Lys Ser Glu Arg Tyr Tyr Leu Leu Pro Asp Glu
245 250 255 245 250 255
Asp Glu Pro His Arg Thr Cys Lys Asn Lys Asn Tyr Ile Pro Arg IleAsp Glu Pro His Arg Thr Cys Lys Asn Lys Asn Tyr Ile Pro Arg Ile
260 265 270 260 265 270
Met Phe Leu Cys Val Cys Ala Arg Pro Arg Phe Arg Asn Gly Glu CysMet Phe Leu Cys Val Cys Ala Arg Pro Arg Phe Arg Asn Gly Glu Cys
275 280 285 275 280 285
Val Phe Asp Gly Lys Ile Gly Cys Phe Pro Leu Val Thr Phe Glu GlnVal Phe Asp Gly Lys Ile Gly Cys Phe Pro Leu Val Thr Phe Glu Gln
290 295 300 290 295 300
Ala Ile Arg Gly Ser Gln Asn Arg Leu Arg Gly Glu Gln Val Ile LysAla Ile Arg Gly Ser Gln Asn Arg Leu Arg Gly Glu Gln Val Ile Lys
305 310 315 320305 310 315 320
Pro Ile Gln Ser Ile Asn Arg Glu Val Ile Arg Ser Phe Met Ile AsnPro Ile Gln Ser Ile Asn Arg Glu Val Ile Arg Ser Phe Met Ile Asn
325 330 335 325 330 335
Arg Val Leu Pro Ala Ile Arg Ala Lys Trp Pro Arg Glu Asp Val HisArg Val Leu Pro Ala Ile Arg Ala Lys Trp Pro Arg Glu Asp Val His
340 345 350 340 345 350
Lys Pro Ile Phe Ile Gln Gln Asp Asn Val Pro Ser His Leu Lys ValLys Pro Ile Phe Ile Gln Gln Asp Asn Val Pro Ser His Leu Lys Val
355 360 365 355 360 365
Asp Asp Pro Gln Phe Arg Glu Val Ala Lys Gln Asp Gly Phe Asp IleAsp Asp Pro Gln Phe Arg Glu Val Ala Lys Gln Asp Gly Phe Asp Ile
370 375 380 370 375 380
Arg Leu Ile Cys Gln Pro Pro Asn Ser Pro Asp Phe Asn Ile Leu AspArg Leu Ile Cys Gln Pro Pro Asn Ser Pro Asp Phe Asn Ile Leu Asp
385 390 395 400385 390 395 400
Leu Gly Phe Phe Arg Ala Ile Gln Ala Ile Gln Tyr Lys Lys Asp AlaLeu Gly Phe Phe Arg Ala Ile Gln Ala Ile Gln Tyr Lys Lys Asp Ala
405 410 415 405 410 415
Lys Thr Leu Lys Asp Leu Ile Pro Ala Val Gln Gln Ala Phe Leu GluLys Thr Leu Lys Asp Leu Ile Pro Ala Val Gln Gln Ala Phe Leu Glu
420 425 430 420 425 430
Tyr Ser Pro Trp Lys Ala Asn Arg Ile Phe Val Thr Leu Gln Thr ValTyr Ser Pro Trp Lys Ala Asn Arg Ile Phe Val Thr Leu Gln Thr Val
435 440 445 435 440 445
Leu Lys Glu Ala Met Lys Ile Lys Gly Cys Asn Lys Ile Lys Ile ProLeu Lys Glu Ala Met Lys Ile Lys Gly Cys Asn Lys Ile Lys Ile Pro
450 455 460 450 455 460
His Ile Gln Lys Gln Arg Leu Glu Arg Glu Asp Arg Leu Pro Leu GlnHis Ile Gln Lys Gln Arg Leu Glu Arg Glu Asp Arg Leu Pro Leu Gln
465 470 475 480465 470 475 480
Ile Pro Cys Glu Ala Ser Leu Leu Ala Glu Ala Leu Ala Ser Leu ProIle Pro Cys Glu Ala Ser Leu Leu Ala Glu Ala Leu Ala Ser Leu Pro
485 490 495 485 490 495
Ala Ala AsnAla Ala Asn
<210> 2<210> 2
<211> 1500<211> 1500
<212> DNA<212> DNA
<213> 人工序列<213> Artificial sequences
<400> 2<400> 2
atggctgacc caatagattc tggcttcgat ctgaacgttc ggttagaaga agatgatgac 60atggctgacc caatagattc tggcttcgat ctgaacgttc ggttagaaga agatgatgac 60
ggcaatcttc cctttgatct caacgagcca atattggaag atcacaacaa tggaattgat 120ggcaatcttc cctttgatct caacgagcca atattggaag atcacaacaa tggaattgat 120
ttgaacttgc cattagatga gtttggtgcc gtcgacttcg actatgtaca aaacctcgct 180ttgaacttgc cattagatga gtttggtgcc gtcgacttcg actatgtaca aaacctcgct 180
gaacaagatg ttgaggctcc cgttcaagta caccctccga agcatgacta tcctgaacat 240gaacaagatg ttgaggctcc cgttcaagta caccctccga agcatgacta tcctgaacat 240
gttagaaaac tagtgtacca agcattgttg atgagaagca agaatgggaa actaggcaat 300gttagaaaac tagtgtacca agcattgttg atgagaagca agaatgggaa actaggcaat 300
catgatacaa caattgtttc cagtcaattt ggagtaaaga ttcgatcagt tcagcgcata 360catgatacaa caattgtttc cagtcaattt ggagtaaaga ttcgatcagt tcagcgcata 360
tggaagcaag gtaaaaacca acttgctcaa aacattccgg tcgtggttgc taatctaaag 420tggaagcaag gtaaaaacca acttgctcaa aacattccgg tcgtggttgc taatctaaag 420
aaaggtagaa gtggccgtaa agcaacccct cttgatttgg aacaattgcg caacattcct 480aaaggtagaa gtggccgtaa agcaacccct cttgatttgg aacaattgcg caacattcct 480
ctcaagcaaa gaatgaccat agaagatgtg tctagtagac ttggtattag caaatctagg 540ctcaagcaaa gaatgaccat agaagatgtg tctagtagac ttggtattag caaatctagg 540
atacaaaggt atttgaaaaa gggtttgctt aggcgccact ctagtagcat aaaaccttac 600atacaaaggt atttgaaaaa gggtttgctt aggcgccact ctagtagcat aaaaccttac 600
ctcaccgatg ctaacaagaa gactaggttg aagtggtgca ttgacatgat tgagcaaggt 660ctcaccgatg ctaacaagaa gactaggttg aagtggtgca ttgacatgat tgagcaaggt 660
ttggttgatg atccaaagtt cagggatttg tttgactttg tgtttattga tgagaagtgg 720ttggttgatg atccaaagtt cagggatttg tttgactttg tgtttattga tgagaagtgg 720
ttctacctct ctcaaaaatc cgagagatac tacttgctac ccgacgaaga tgaaccacat 780ttctacctct ctcaaaaatc cgagagatac tacttgctac ccgacgaaga tgaaccacat 780
cgcacttgca agaacaagaa ttacatccct aggatcatgt ttttgtgtgt ttgtgctcgg 840cgcacttgca agaacaagaa ttacatccct aggatcatgt ttttgtgtgt ttgtgctcgg 840
ccaagattta gaaatggaga atgtgtgttt gatggcaaaa taggttgttt tccactagtc 900ccaagattta gaaatggaga atgtgtgttt gatggcaaaa taggttgttt tccactagtc 900
acttttgaac aagctattag aggaagccaa aaccgtcttc gtggagaaca agtaatcaag 960acttttgaac aagctattag aggaagccaa aaccgtcttc gtggagaaca agtaatcaag 960
ccaattcaat caattaatag ggaagtgata agaagtttca tgataaatag agtgttgcct 1020ccaattcaat caattaatag ggaagtgata agaagtttca tgataaatag agtgttgcct 1020
gcaattagag caaagtggcc aagagaagat gtacacaagc caattttcat acaacaagat 1080gcaattagag caaagtggcc aagagaagat gtacacaagc caattttcat acaacaagat 1080
aatgttccat ctcatttaaa ggtggatgat cctcagtttc gtgaggttgc taagcaagat 1140aatgttccat ctcatttaaa ggtggatgat cctcagtttc gtgaggttgc taagcaagat 1140
gggtttgaca ttaggctcat atgtcaacca cccaattctc cagattttaa cattctagat 1200gggtttgaca ttaggctcat atgtcaacca cccaattctc cagattttaa cattctagat 1200
ttgggttttt ttcgagctat tcaagcaatt caatacaaga aagatgctaa gacattgaaa 1260ttgggttttt ttcgagctat tcaagcaatt caatacaaga aagatgctaa gacattgaaa 1260
gatctaattc cagcagtcca acaggcattt ttggagtact ctccatggaa agcaaatagg 1320gatctaattc cagcagtcca acaggcattt ttggagtact ctccatggaa agcaaatagg 1320
atatttgtga cactacaaac tgttttgaag gaagcaatga agataaaagg ttgcaacaaa 1380atatttgtga cactacaaac tgttttgaag gaagcaatga agataaaagg ttgcaacaaa 1380
atcaaaattc ctcacatcca gaaacaaaga cttgagagag aagataggct gccattgcaa 1440atcaaaattc ctcacatcca gaaacaaaga cttgagagag aagataggct gccattgcaa 1440
atcccttgtg aagcttcctt gctagccgaa gcacttgcaa gccttcctgc agctaattag 1500atcccttgtg aagcttcctt gctagccgaa gcacttgcaa gccttcctgc agctaattag 1500
<210> 3<210> 3
<211> 3435<211> 3435
<212> DNA<212> DNA
<213> 毛竹基因组<213> Phyllostachys pubescens genome
<400> 3<400> 3
tactccctcc atacccgaaa ttcctgacgt ttaggacatg attgtggtaa ccaaggagtg 60tactccctcc atacccgaaa ttcctgacgt ttaggacatg attgtggtaa ccaaggagtg 60
attaattagg ggttagtttt ccatctttgc ccctaataaa tatggttacg ggtgctcttt 120attaattagg ggttagtttt ccatctttgc ccctaataaa tatggttacg ggtgctcttt 120
gtacgagaaa gtaaaccagc tcgactggct agcgcgcgga ggcctcagtc ctgtggtgcg 180gtacgagaaa gtaaaccagc tcgactggct agcgcgcgga ggcctcagtc ctgtggtgcg 180
cgttcgatac ctcgcggacg caggtttttt tcttgttgct gtttattcat ttttgcatgg 240cgttcgatac ctcgcggacg caggtttttt tcttgttgct gtttattcat ttttgcatgg 240
cactgtttag gcaacgcacg tcgcgcgcgc ttagccgctg cgggcgttag ttttcgagtg 300cactgtttag gcaacgcacg tcgcgcgcgc ttagccgctg cgggcgttag ttttcgagtg 300
gatttgggcc tggcgcacgg aggaggttgc atggctgccc gaaaatttcg ttgcatgcac 360gatttgggcc tggcgcacgg aggaggttgc atggctgccc gaaaatttcg ttgcatgcac 360
tggattttca aaattttgtc ctcgcgctgt ggaggctcgt ttgaggccgc gttttttttc 420tggattttca aaattttgtc ctcgcgctgt ggaggctcgt ttgaggccgc gtttttttttc 420
atctggcgcg ctggaaggcc gacgtttgga gtgctcgttg cttgttctat ttaaacgcct 480atctggcgcg ctggaaggcc gacgtttgga gtgctcgttg cttgttctat ttaaacgcct 480
ggaaccttcc ttgttgtctt cctatgccgg actcctgtac tatggctgac ccaatagatt 540ggaaccttcc ttgttgtctt cctatgccgg actcctgtac tatggctgac ccaatagatt 540
ctggcttcga tctgaacgtt cggttagaag aagatgatga cggcaatctt ccctttgatc 600ctggcttcga tctgaacgtt cggttagaag aagatgatga cggcaatctt ccctttgatc 600
tcaacgagcc aatattggaa gatcacaaca atggtaagca aaaacgtcaa attagtttct 660tcaacgagcc aatattggaa gatcacaaca atggtaagca aaaacgtcaa attagtttct 660
cagtttctcg tttccttttt tctttactga gcttgtcgtt tcctttttcg ataggaattg 720cagtttctcg tttcctttttt tctttactga gcttgtcgtt tcctttttcg ataggaattg 720
atttgaactt gccattagat gagtttggtg ctgtcgactt cgactatgta caaaacctcg 780atttgaactt gccattagat gagtttggtg ctgtcgactt cgactatgta caaaacctcg 780
ctggtaagca tggctagtat tatgaattcg cttgtttttt tatttccttt tgctggaaca 840ctggtaagca tggctagtat tatgaattcg cttgttttttt tatttccttt tgctggaaca 840
tgccgtgaat aatagtatta tgaactcgct tgttttttat ttccttttac tagaacatgt 900tgccgtgaat aatagtatta tgaactcgct tgtttttttat ttccttttac tagaacatgt 900
gcttgtttta ttcctatagc tagatcatga cgtcaatact ttttacgatg aatatgctcg 960gcttgtttta ttcctatagc tagatcatga cgtcaatact ttttacgatg aatatgctcg 960
ttacagtata gctagaacat gccgtgacta catagtagta tgaatatgct tgttttattt 1020ttacagtata gctagaacat gccgtgacta catagtagta tgaatatgct tgttttattt 1020
ctataactat aacatgccgt gagtatattt agatcatgcc gtgagtacta agtactatta 1080ctataactat aacatgccgt gagtatattt agatcatgcc gtgagtacta agtactatta 1080
aaatgcttgt tttttatttc cttttgctag aacaagatgt tgaggctccc gttcaagtac 1140aaatgcttgt ttttatttc cttttgctag aacaagatgt tgaggctccc gttcaagtac 1140
accctccgaa gcatgactat cctgaacatg ttagaaaact agtgtaccaa gcattgttga 1200accctccgaa gcatgactat cctgaacatg ttagaaaact agtgtaccaa gcattgttga 1200
tgagaagcaa gaatgggaaa ctaggcaatc atgatacaac aattgtttcc agtcaatttg 1260tgagaagcaa gaatgggaaa ctaggcaatc atgatacaac aattgtttcc agtcaatttg 1260
gagtaaagat tcgatcagtt cagcgcatat ggaagcaagg taaaaaccaa cttgctcaaa 1320gagtaaagat tcgatcagtt cagcgcatat ggaagcaagg taaaaaccaa cttgctcaaa 1320
acattccggt cgtggttgct aatctaaaga aaggtagaag tggccgtaaa gcaacccctc 1380acattccggt cgtggttgct aatctaaaga aaggtagaag tggccgtaaa gcaacccctc 1380
ttgatttgga acaattgcgc aacattcctc tcaagcaaag aatgaccata gaagatgtgt 1440ttgatttgga acaattgcgc aacattcctc tcaagcaaag aatgaccata gaagatgtgt 1440
ctagtagact tggtattagc aaatctagga tacaaaggta tttgaaaaag ggtttgctta 1500ctagtagact tggtattagc aaatctagga tacaaaggta tttgaaaaag ggtttgctta 1500
ggcgccactc tagtagcata aaaccttacc tcaccgatgc taacaagaag actaggttga 1560ggcgccactc tagtagcata aaaccttacc tcaccgatgc taacaagaag actaggttga 1560
agtggtgcat tgacatgatt gagcaaggtt tggttgatga tccaaagttc agggatttgt 1620agtggtgcat tgacatgatt gagcaaggtt tggttgatga tccaaagttc agggatttgt 1620
ttgactttgt gtttattgat gagaagtggt tctacctctc tcaaaaatcc gagagatact 1680ttgactttgt gtttattgat gagaagtggt tctacctctc tcaaaaatcc gagagatact 1680
acttgctacc cgacgaagat gaaccacatc gcacttgcaa gaacaagaat tacatcccta 1740acttgctacc cgacgaagat gaaccacatc gcacttgcaa gaacaagaat tacatcccta 1740
ggatcatgtt tttgtgtgtt tgtgctcggc caagatttag aaatggagaa tgtgtgtttg 1800ggatcatgtt tttgtgtgtt tgtgctcggc caagatttag aaatggagaa tgtgtgtttg 1800
atggcaaaat aggttgtttt ccactagtca cttttgaaca agctattaga ggaagccaaa 1860atggcaaaat aggttgtttt ccactagtca cttttgaaca agctattaga ggaagccaaa 1860
accgtcttcg tggagaacaa gtaatcaagc caattcaatc aatcaatagg gaagtgataa 1920accgtcttcg tggagaacaa gtaatcaagc caattcaatc aatcaatagg gaagtgataa 1920
gagatttcat gataaataga gtgttgcctg caattagagc aaagtggcca agagaagatg 1980gagatttcat gataaataga gtgttgcctg caattagagc aaagtggcca agagaagatg 1980
tacacaagcc aattttcata caacaagata atgctccatc tcatttaaag gtggatgatc 2040tacacaagcc aattttcata caacaagata atgctccatc tcatttaaag gtggatgatc 2040
ctcagttttg tgaggttgct aagcaagatg ggtttgacat taggctcata tgtcaaccac 2100ctcagttttg tgaggttgct aagcaagatg ggtttgacat taggctcata tgtcaaccac 2100
ccaattctcc agattttaac attctagatt tgggtttttt tcgagctatt caagcaattc 2160ccaattctcc agattttaac attctagatt tgggttttttt tcgagctatt caagcaattc 2160
aatacaagaa agatgctaag acattgaaag atctaattcc agcagtccaa caggtaaatg 2220aatacaagaa agatgctaag acattgaaag atctaattcc agcagtccaa caggtaaatg 2220
atcatccatt acagtgttta aattgatctt gaacaaataa tataatcact gatcttgaac 2280atcatccatt acagtgttta aattgatctt gaacaaataa tataatcact gatcttgaac 2280
atgttttgta ggcatttttg gagtactctc catggaaagc aaataggata tttgtgacac 2340atgttttgta ggcatttttg gagtactctc catggaaagc aaataggata tttgtgacac 2340
tacaaactgt tttgaaggaa gcaatgaaga taaaaggttg caacaaaatc aaaattcctc 2400tacaaactgt tttgaaggaa gcaatgaaga taaaaggttg caacaaaatc aaaattcctc 2400
acatccagaa acaaagactt gagagagaag ataggctgcc attgcaaatc ccttgtgaag 2460acatccagaa acaaagactt gagagagaag ataggctgcc attgcaaatc ccttgtgaag 2460
cttccttgct agccgaagca cttgcaagcc ttcctgcggc taattagaag atgcaagcat 2520cttccttgct agccgaagca cttgcaagcc ttcctgcggc taattagaag atgcaagcat 2520
gttactcttt tgcagcagca agcatgtaag aagacgcgag catgttagta gcaaactatg 2580gttactcttt tgcagcagca agcatgtaag aagacgcgag catgttagta gcaaactatg 2580
aacaaactag tttatgcatg tagtagtatg ttagcttgtg caccttagtc atctcgtccc 2640aacaaactag tttatgcatg tagtagtatg ttagcttgtg caccttagtc atctcgtccc 2640
aaccgcttga taacatgctc aggaagaagt attgtgtcac catccatttc aagtttctcc 2700aaccgcttga taacatgctc aggaagaagt attgtgtcac catccatttc aagtttctcc 2700
acatcaggaa tgtagacctc acaatcaaac ttttccatgt catcgagcca cttcgctgtc 2760acatcaggaa tgtagacctc acaatcaaac ttttccatgt catcgagcca cttcgctgtc 2760
atgtcgtagt cttcatgtaa aaggccacaa cgggcacaca tgcgagcttc gcggcgagct 2820atgtcgtagt cttcatgtaa aaggccacaa cgggcacaca tgcgagcttc gcggcgagct 2820
tggtagcagg cttctccgaa gacgccgccg gcgtggaacg taacacagcg aggacacaga 2880tggtagcagg cttctccgaa gacgccgccg gcgtggaacg taacacagcg aggacacaga 2880
gactcgacgg agtcgggatc gacggtgtcg ggcaccatct cgagggagtc tgcaaccatg 2940gactcgacgg agtcgggatc gacggtgtcg ggcaccatct cgagggagtc tgcaaccatg 2940
tcgacggagt ccggcagctc ctcgacggag tccggcacca tgtcgacggt gtccggcagc 3000tcgacggagt ccggcagctc ctcgacggag tccggcacca tgtcgacggt gtccggcagc 3000
tcctcgacgg agtctggcac ctcctgcggc gccatgtcca cggtgtccag cgacgctatg 3060tcctcgacgg agtctggcac ctcctgcggc gccatgtcca cggtgtccag cgacgctatg 3060
gagcccgacg agatgtcctg cacggcgacg tccagcgccg caacggactc cgtcgtttcc 3120gagcccgacg agatgtcctg cacggcgacg tccagcgccg caacggactc cgtcgtttcc 3120
atctgatccg acgaggcatc gacgtcctgc gacgagcgtg gcggcgagag cacggcgagc 3180atctgatccg acgaggcatc gacgtcctgc gacgagcgtg gcggcgagag cacggcgagc 3180
gggcaggcga gcgggcaggc gagcgagcca ttcgcgcgag cgatgaatgc gagctgctgt 3240gggcaggcga gcgggcaggc gagcgagcca ttcgcgcgag cgatgaatgc gagctgctgt 3240
accaggcgca cacacgcgca atcaatgcgg gcgagtaacg atgcgagcat gcgcggcgga 3300accaggcgca cacacgcgca atcaatgcgg gcgagtaacg atgcgagcat gcgcggcgga 3300
agcgcaacag acgggcagca gcgcatggcc aggggcaaac gcgtgaaaag aagaccacgc 3360agcgcaacag acgggcagca gcgcatggcc aggggcaaac gcgtgaaaag aagaccacgc 3360
gaggccacaa cgtcagcttt tgcgcaaacg ggcacttcgc ctagaacgtc aggaatttcg 3420gaggccacaa cgtcagcttt tgcgcaaacg ggcacttcgc ctagaacgtc aggaatttcg 3420
ggtatggagg gagta 3435ggtatggagg gagta 3435
<210> 4<210> 4
<211> 1500<211> 1500
<212> DNA<212> DNA
<213> 人工序列<213> Artificial sequences
<400> 4<400> 4
atggctgacc caatagattc tggcttcgat ctgaacgttc ggttagaaga agatgatgac 60atggctgacc caatagattc tggcttcgat ctgaacgttc ggttagaaga agatgatgac 60
ggcaatcttc cctttgatct caacgagcca atattggaag atcacaacaa tggaattgat 120ggcaatcttc cctttgatct caacgagcca atattggaag atcacaacaa tggaattgat 120
ttgaacttgc cattagatga gtttggtgcc gtcgacttcg actatgtaca aaacctcgct 180ttgaacttgc cattagatga gtttggtgcc gtcgacttcg actatgtaca aaacctcgct 180
gaacaagatg ttgaggctcc cgttcaagta caccctccga agcatgacta tcctgaacat 240gaacaagatg ttgaggctcc cgttcaagta caccctccga agcatgacta tcctgaacat 240
gttagaaaac tagtgtacca agcattgttg atgagaagca agaatgggaa actaggcaat 300gttagaaaac tagtgtacca agcattgttg atgagaagca agaatgggaa actaggcaat 300
catgatacaa caattgtttc cagtcaattt ggagtaaaga ttcgatcagt tcagcgcata 360catgatacaa caattgtttc cagtcaattt ggagtaaaga ttcgatcagt tcagcgcata 360
tggaagcaag gtaaaaacca acttgctcaa aacattccgg tcgtggttgc taatctaaag 420tggaagcaag gtaaaaacca acttgctcaa aacattccgg tcgtggttgc taatctaaag 420
aaaggtagaa gtggccgtaa agcaacccct cttgatttgg aacaattgcg caacattcct 480aaaggtagaa gtggccgtaa agcaacccct cttgatttgg aacaattgcg caacattcct 480
ctcaagcaaa gaatgaccat agaagatgtg tctagtagac ttggtattag caaatctagg 540ctcaagcaaa gaatgaccat agaagatgtg tctagtagac ttggtattag caaatctagg 540
atacaaaggt atttgaaaaa gggtttgctt aggcgccact ctagtagcat aaaaccttac 600atacaaaggt atttgaaaaa gggtttgctt aggcgccact ctagtagcat aaaaccttac 600
ctcaccgatg ctaacaagaa gactaggttg aagtggtgca ttgacatgat tgagcaaggt 660ctcaccgatg ctaacaagaa gactaggttg aagtggtgca ttgacatgat tgagcaaggt 660
ttggttgatg atccaaagtt cagggatttg tttgactttg tgtttattga tgagaagtgg 720ttggttgatg atccaaagtt cagggatttg tttgactttg tgtttattga tgagaagtgg 720
ttctacctct ctcaaaaatc cgagagatac tacttgctac ccgacgaaga tgaaccacat 780ttctacctct ctcaaaaatc cgagagatac tacttgctac ccgacgaaga tgaaccacat 780
cgcacttgca agaacaagaa ttacatccct aggatcatgt ttttgtgtgt ttgtgctcgg 840cgcacttgca agaacaagaa ttacatccct aggatcatgt ttttgtgtgt ttgtgctcgg 840
ccaagattta gaaatggaga atgtgtgttt gatggcaaaa taggttgttt tccactagtc 900ccaagattta gaaatggaga atgtgtgttt gatggcaaaa taggttgttt tccactagtc 900
acttttgaac aagctattag aggaagccaa aaccgtcttc gtggagaaca agtaatcaag 960acttttgaac aagctattag aggaagccaa aaccgtcttc gtggagaaca agtaatcaag 960
ccaattcaat caattaatag ggaagtgata agagatttca tgataaatag agtgttgcct 1020ccaattcaat caattaatag ggaagtgata agagatttca tgataaatag agtgttgcct 1020
gcaattagag caaagtggcc aagagaagat gtacacaagc caattttcat acaacaagat 1080gcaattagag caaagtggcc aagagaagat gtacacaagc caattttcat acaacaagat 1080
aatgttccat ctcatttaaa ggtggatgat cctcagtttc gtgaggttgc taagcaagat 1140aatgttccat ctcatttaaa ggtggatgat cctcagtttc gtgaggttgc taagcaagat 1140
gggtttgaca ttaggctcat atgtcaacca cccaattctc cagattttaa cattctagat 1200gggtttgaca ttaggctcat atgtcaacca cccaattctc cagattttaa cattctagat 1200
ttgggttttt ttcgagctat tcaagcaatt caatacaaga aagatgctaa gacattgaaa 1260ttgggttttt ttcgagctat tcaagcaatt caatacaaga aagatgctaa gacattgaaa 1260
gatctaattc cagcagtcca acaggcattt ttggagtact ctccatggaa agcaaatagg 1320gatctaattc cagcagtcca acaggcattt ttggagtact ctccatggaa agcaaatagg 1320
atatttgtga cactacaaac tgttttgaag gaagcaatga agataaaagg ttgcaacaaa 1380atatttgtga cactacaaac tgttttgaag gaagcaatga agataaaagg ttgcaacaaa 1380
atcaaaattc ctcacatcca gaaacaaaga cttgagagag aagataggct gccattgcaa 1440atcaaaattc ctcacatcca gaaacaaaga cttgagagag aagataggct gccattgcaa 1440
atcccttgtg aagcttcctt gctagccgaa gcacttgcaa gccttcctgc agctaattag 1500atcccttgtg aagcttcctt gctagccgaa gcacttgcaa gccttcctgc agctaattag 1500
<210> 5<210> 5
<211> 499<211> 499
<212> PRT<212> PRT
<213> 人工序列<213> Artificial sequences
<400> 5<400> 5
Met Ala Asp Pro Ile Asp Ser Gly Phe Asp Leu Asn Val Arg Leu GluMet Ala Asp Pro Ile Asp Ser Gly Phe Asp Leu Asn Val Arg Leu Glu
1 5 10 151 5 10 15
Glu Asp Asp Asp Gly Asn Leu Pro Phe Asp Leu Asn Glu Pro Ile LeuGlu Asp Asp Asp Gly Asn Leu Pro Phe Asp Leu Asn Glu Pro Ile Leu
20 25 30 20 25 30
Glu Asp His Asn Asn Gly Ile Asp Leu Asn Leu Pro Leu Asp Glu PheGlu Asp His Asn Asn Gly Ile Asp Leu Asn Leu Pro Leu Asp Glu Phe
35 40 45 35 40 45
Gly Ala Val Asp Phe Asp Tyr Val Gln Asn Leu Ala Glu Gln Asp ValGly Ala Val Asp Phe Asp Tyr Val Gln Asn Leu Ala Glu Gln Asp Val
50 55 60 50 55 60
Glu Ala Pro Val Gln Val His Pro Pro Lys His Asp Tyr Pro Glu HisGlu Ala Pro Val Gln Val His Pro Pro Lys His Asp Tyr Pro Glu His
65 70 75 8065 70 75 80
Val Arg Lys Leu Val Tyr Gln Ala Leu Leu Met Arg Ser Lys Asn GlyVal Arg Lys Leu Val Tyr Gln Ala Leu Leu Met Arg Ser Lys Asn Gly
85 90 95 85 90 95
Lys Leu Gly Asn His Asp Thr Thr Ile Val Ser Ser Gln Phe Gly ValLys Leu Gly Asn His Asp Thr Thr Ile Val Ser Ser Gln Phe Gly Val
100 105 110 100 105 110
Lys Ile Arg Ser Val Gln Arg Ile Trp Lys Gln Gly Lys Asn Gln LeuLys Ile Arg Ser Val Gln Arg Ile Trp Lys Gln Gly Lys Asn Gln Leu
115 120 125 115 120 125
Ala Gln Asn Ile Pro Val Val Val Ala Asn Leu Lys Lys Gly Arg SerAla Gln Asn Ile Pro Val Val Val Val Ala Asn Leu Lys Lys Gly Arg Ser
130 135 140 130 135 140
Gly Arg Lys Ala Thr Pro Leu Asp Leu Glu Gln Leu Arg Asn Ile ProGly Arg Lys Ala Thr Pro Leu Asp Leu Glu Gln Leu Arg Asn Ile Pro
145 150 155 160145 150 155 160
Leu Lys Gln Arg Met Thr Ile Glu Asp Val Ser Ser Arg Leu Gly IleLeu Lys Gln Arg Met Thr Ile Glu Asp Val Ser Ser Arg Leu Gly Ile
165 170 175 165 170 175
Ser Lys Ser Arg Ile Gln Arg Tyr Leu Lys Lys Gly Leu Leu Arg ArgSer Lys Ser Arg Ile Gln Arg Tyr Leu Lys Lys Gly Leu Leu Arg Arg
180 185 190 180 185 190
His Ser Ser Ser Ile Lys Pro Tyr Leu Thr Asp Ala Asn Lys Lys ThrHis Ser Ser Ser Ile Lys Pro Tyr Leu Thr Asp Ala Asn Lys Lys Thr
195 200 205 195 200 205
Arg Leu Lys Trp Cys Ile Asp Met Ile Glu Gln Gly Leu Val Asp AspArg Leu Lys Trp Cys Ile Asp Met Ile Glu Gln Gly Leu Val Asp Asp
210 215 220 210 215 220
Pro Lys Phe Arg Asp Leu Phe Asp Phe Val Phe Ile Asp Glu Lys TrpPro Lys Phe Arg Asp Leu Phe Asp Phe Val Phe Ile Asp Glu Lys Trp
225 230 235 240225 230 235 240
Phe Tyr Leu Ser Gln Lys Ser Glu Arg Tyr Tyr Leu Leu Pro Asp GluPhe Tyr Leu Ser Gln Lys Ser Glu Arg Tyr Tyr Leu Leu Pro Asp Glu
245 250 255 245 250 255
Asp Glu Pro His Arg Thr Cys Lys Asn Lys Asn Tyr Ile Pro Arg IleAsp Glu Pro His Arg Thr Cys Lys Asn Lys Asn Tyr Ile Pro Arg Ile
260 265 270 260 265 270
Met Phe Leu Cys Val Cys Ala Arg Pro Arg Phe Arg Asn Gly Glu CysMet Phe Leu Cys Val Cys Ala Arg Pro Arg Phe Arg Asn Gly Glu Cys
275 280 285 275 280 285
Val Phe Asp Gly Lys Ile Gly Cys Phe Pro Leu Val Thr Phe Glu GlnVal Phe Asp Gly Lys Ile Gly Cys Phe Pro Leu Val Thr Phe Glu Gln
290 295 300 290 295 300
Ala Ile Arg Gly Ser Gln Asn Arg Leu Arg Gly Glu Gln Val Ile LysAla Ile Arg Gly Ser Gln Asn Arg Leu Arg Gly Glu Gln Val Ile Lys
305 310 315 320305 310 315 320
Pro Ile Gln Ser Ile Asn Arg Glu Val Ile Arg Asp Phe Met Ile AsnPro Ile Gln Ser Ile Asn Arg Glu Val Ile Arg Asp Phe Met Ile Asn
325 330 335 325 330 335
Arg Val Leu Pro Ala Ile Arg Ala Lys Trp Pro Arg Glu Asp Val HisArg Val Leu Pro Ala Ile Arg Ala Lys Trp Pro Arg Glu Asp Val His
340 345 350 340 345 350
Lys Pro Ile Phe Ile Gln Gln Asp Asn Val Pro Ser His Leu Lys ValLys Pro Ile Phe Ile Gln Gln Asp Asn Val Pro Ser His Leu Lys Val
355 360 365 355 360 365
Asp Asp Pro Gln Phe Arg Glu Val Ala Lys Gln Asp Gly Phe Asp IleAsp Asp Pro Gln Phe Arg Glu Val Ala Lys Gln Asp Gly Phe Asp Ile
370 375 380 370 375 380
Arg Leu Ile Cys Gln Pro Pro Asn Ser Pro Asp Phe Asn Ile Leu AspArg Leu Ile Cys Gln Pro Pro Asn Ser Pro Asp Phe Asn Ile Leu Asp
385 390 395 400385 390 395 400
Leu Gly Phe Phe Arg Ala Ile Gln Ala Ile Gln Tyr Lys Lys Asp AlaLeu Gly Phe Phe Arg Ala Ile Gln Ala Ile Gln Tyr Lys Lys Asp Ala
405 410 415 405 410 415
Lys Thr Leu Lys Asp Leu Ile Pro Ala Val Gln Gln Ala Phe Leu GluLys Thr Leu Lys Asp Leu Ile Pro Ala Val Gln Gln Ala Phe Leu Glu
420 425 430 420 425 430
Tyr Ser Pro Trp Lys Ala Asn Arg Ile Phe Val Thr Leu Gln Thr ValTyr Ser Pro Trp Lys Ala Asn Arg Ile Phe Val Thr Leu Gln Thr Val
435 440 445 435 440 445
Leu Lys Glu Ala Met Lys Ile Lys Gly Cys Asn Lys Ile Lys Ile ProLeu Lys Glu Ala Met Lys Ile Lys Gly Cys Asn Lys Ile Lys Ile Pro
450 455 460 450 455 460
His Ile Gln Lys Gln Arg Leu Glu Arg Glu Asp Arg Leu Pro Leu GlnHis Ile Gln Lys Gln Arg Leu Glu Arg Glu Asp Arg Leu Pro Leu Gln
465 470 475 480465 470 475 480
Ile Pro Cys Glu Ala Ser Leu Leu Ala Glu Ala Leu Ala Ser Leu ProIle Pro Cys Glu Ala Ser Leu Leu Ala Glu Ala Leu Ala Ser Leu Pro
485 490 495 485 490 495
Ala Ala AsnAla Ala Asn
<210> 6<210> 6
<211> 779<211> 779
<212> DNA<212> DNA
<213> 人工序列<213> Artificial sequences
<400> 6<400> 6
tactccctcc atacccgaaa ttcctgacgt ttaggacatg attgtggtaa ccaaggagtg 60tactccctcc atacccgaaa ttcctgacgt ttaggacatg attgtggtaa ccaaggagtg 60
attaattagg ggttagtttt ccatctttgc ccctaataaa tatggttacg ggtgctcttt 120attaattagg ggttagtttt ccatctttgc ccctaataaa tatggttacg ggtgctcttt 120
gtacgagaaa gtaaaccagc tcgactggct agcgcgcgga ggcctcagtc ctgtggtgcg 180gtacgagaaa gtaaaccagc tcgactggct agcgcgcgga ggcctcagtc ctgtggtgcg 180
cgttcgatac ctcgcggacg caggtttttt tcttgttgct gtttattcat ttttgcatgg 240cgttcgatac ctcgcggacg caggtttttt tcttgttgct gtttattcat ttttgcatgg 240
cactgtttag gcaacgcacg tcgcgcgcgc ttagccgctg cgggcgttag ttttcgagtg 300cactgtttag gcaacgcacg tcgcgcgcgc ttagccgctg cgggcgttag ttttcgagtg 300
gatttgggcc tggcgcacgg aggaggttgc atggctccgg cagctcctcg acggagtctg 360gatttgggcc tggcgcacgg aggaggttgc atggctccgg cagctcctcg acggagtctg 360
gcacctcctg cggcgccatg tccacggtgt ccagcgacgc tatggagccc gacgagatgt 420gcacctcctg cggcgccatg tccacggtgt ccagcgacgc tatggagccc gacgagatgt 420
cctgcacggc gacgtccagc gccgcaacgg actccgtcgt ttccatctga tccgacgagg 480cctgcacggc gacgtccagc gccgcaacgg actccgtcgt ttccatctga tccgacgagg 480
catcgacgtc ctgcgacgag cgtggcggcg agagcacggc gagcgggcag gcgagcgggc 540catcgacgtc ctgcgacgag cgtggcggcg agagcacggc gagcgggcag gcgagcgggc 540
aggcgagcga gccattcgcg cgagcgatga atgcgagctg ctgtaccagg cgcacacacg 600aggcgagcga gccattcgcg cgagcgatga atgcgagctg ctgtaccagg cgcacacacg 600
cgcaatcaat gcgggcgagt aacgatgcga gcatgcgcgg cggaagcgca acagacgggc 660cgcaatcaat gcgggcgagt aacgatgcga gcatgcgcgg cggaagcgca acagacgggc 660
agcagcgcat ggccaggggc aaacgcgtga aaagaagacc acgcgaggcc acaacgtcag 720agcagcgcat ggccaggggc aaacgcgtga aaagaagacc acgcgaggcc acaacgtcag 720
cttttgcgca aacgggcact tcgcctagaa cgtcaggaat ttcgggtatg gagggagta 779cttttgcgca aacgggcact tcgcctagaa cgtcaggaat ttcgggtatg gagggagta 779
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710042523.6A CN106916799B (en) | 2017-01-20 | 2017-01-20 | A Ppmar1 transposase D332S mutant with high catalytic activity and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710042523.6A CN106916799B (en) | 2017-01-20 | 2017-01-20 | A Ppmar1 transposase D332S mutant with high catalytic activity and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106916799A CN106916799A (en) | 2017-07-04 |
| CN106916799B true CN106916799B (en) | 2020-09-11 |
Family
ID=59454432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710042523.6A Expired - Fee Related CN106916799B (en) | 2017-01-20 | 2017-01-20 | A Ppmar1 transposase D332S mutant with high catalytic activity and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106916799B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114875008A (en) * | 2021-11-22 | 2022-08-09 | 浙江农林大学 | Ppmar1 transposase L479A mutant with high catalytic activity and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103627684B (en) * | 2013-11-20 | 2016-07-06 | 浙江农林大学 | The high activity Mariner-Like transposase of artificial optimization |
| CN103602654B (en) * | 2013-11-20 | 2016-02-24 | 浙江农林大学 | Engineered high reactivity Mariner-Like transposase |
-
2017
- 2017-01-20 CN CN201710042523.6A patent/CN106916799B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN106916799A (en) | 2017-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103602654B (en) | Engineered high reactivity Mariner-Like transposase | |
| Nandy et al. | Heat‐shock‐inducible CRISPR/Cas9 system generates heritable mutations in rice | |
| CN106957830B (en) | Cas9 nuclease delta F916 and application thereof | |
| JP7011590B2 (en) | Protected DNA template and method of use for increased intracellular gene recombination and homologous recombination | |
| US11136588B2 (en) | Method for producing whole plants from protoplasts | |
| CN107488649A (en) | A kind of fusion protein of Cpf1 and p300 Core domains, corresponding DNA target are to activation system and application | |
| CN103627684B (en) | The high activity Mariner-Like transposase of artificial optimization | |
| WO2015079056A1 (en) | Somatic human cell line mutations | |
| CN106754815B (en) | A Ppmar1 transposase C296I mutant with high catalytic activity and its application | |
| EP3775223B1 (en) | Method for increasing the expression level of a nucleic acid molecule of interest in a cell | |
| CN112980846B (en) | Construction method of Pax2 conditional gene knockout mouse model | |
| CN107298702A (en) | A rice grain shape-related protein and its coding gene | |
| JP4158920B2 (en) | Induction method of genome rearrangement by intracellular activation of thermostable frequent DNA-cleaving enzyme | |
| Johnson et al. | Development of mPing‐based activation tags for crop insertional mutagenesis | |
| CN106916799B (en) | A Ppmar1 transposase D332S mutant with high catalytic activity and its application | |
| JP5733609B2 (en) | A novel promoter used to transform algae | |
| CN106701711B (en) | A Ppmar1 transposase S171A mutant with high catalytic activity and its application | |
| CN106701710B (en) | A Ppmar1 transposase F302Q mutant with high catalytic activity and its application | |
| CN106811447B (en) | Ppmar1 transposase V376A mutant with high catalytic activity and application thereof | |
| CN114875008A (en) | Ppmar1 transposase L479A mutant with high catalytic activity and application thereof | |
| CN114875009A (en) | A Ppmar1 transposase L477A-L479A mutant with high catalytic activity and its application | |
| CN114958798A (en) | High catalytic activityPpmar1Transposase L477A-P478E-L479I mutant and application thereof | |
| CN114854709A (en) | Ppmar2 transposase I441A mutant with high catalytic activity and application thereof | |
| CN114854710A (en) | A catalyst having high activityPpmar2NATransposon G25A-C27A mutant and application thereof | |
| CN103642931A (en) | Method for quickly identifying influence of uORF (Upstream Open Reading Frame) on translational level |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200911 Termination date: 20220120 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |